GPT Healthcare Limited

Healthcare · Healthcare Services

NSE: GPTHEALTH BSE: 544131
₹150.74
▼ -3.06 (-1.99%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
71/100
Strong
Valuation
32/100
Fairly Valued
Momentum
28/100
Bearish

QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,237 Cr
PE (TTM)
26.2
Industry median 50.2 (44 companies)
Price to Book
4.6
PEG (TTM)
-30.4
Institutions holding %
9.97%
FII + DII, latest filed period
Piotroski Score
6
Relative return vs Nifty50, qtr %
6.1
Relative return vs Sector, qtr %
3.2
Free Cash Flow
₹39 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
64.89%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
-3.98%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
18.08%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
13.00%
as of March 31, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
17.83%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
1.12
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.06
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
7.94
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
11.53%
as of March 31, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
15.31%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
14.16%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
9.84%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
16.36%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
16.98%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

6 of 7 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 6)
  • Yes Debt to equity is below 0.5 (0.06)
  • Yes Return on equity is 15% or more (17.0%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Fair Value Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.0%
Low 150.0000 · High 156.1800
1W return
-6.7%
Low 150.0000 · High 166.8000
1M return
-1.5%
Low 150.0000 · High 170.9000
52W return
2.2%
Low 115.0000 · High 175.0000
Lifetime High ₹200.7000 (Feb. 29, 2024)
Lifetime Low ₹115.3100 (March 30, 2026)

Full price history and technicals →

EMA & SMA

Bullish1
Bearish5
5D
155.6
10D
157.9
20D
158.5
50D
157.0
100D
152.6
200D
142.5

Delivery and volume

Day avg. delivery
55.4%
Week avg. delivery
60.2%
Month avg. delivery
54.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

152.31
Pivot
First resistance154.61
Second resistance158.49
Third resistance160.79
First support148.43
Second support146.13
Third support142.25
Day RSI35.2
Day MFI39.9
Day MACD-0.10
Day MACD signal1.17

Beta

1M0.76
3M0.53
1Y0.53
3Y0.79

Price change analysis

↓ -1.5%
Over 1 Month
LowHigh
150.00170.90
↑ 0.5%
Over 3 Months
LowHigh
147.94175.00
↑ 26.5%
Over 6 Months
LowHigh
116.00175.00
↑ 2.2%
Over 1 Year
LowHigh
115.00175.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 26.2 (own history: 22.4–30.1)
Fair Value Zone
Revenue (June 30, 2026)
₹126 Cr
Net profit (June 30, 2026)
₹13 Cr
Basic EPS (June 30, 2026)
₹1.5500

Ranks #33 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter65.57%
  • Mutual funds4.65%
  • FII/FPI3.03%
  • Other DII2.29%
  • Public24.46%

Largest holders

NameCategoryShares %Shares
GPT Sons Private LimitedPromoter65.5700%53804700
Bandhan Small Cap FundPublic4.6500%3813360
India Capital Growth Fund LimitedPublic2.7400%2250168
Rajasthan Global Securities Private LimitedPublic1.2000%983374

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 65.57% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 2.81% to 3.03% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 4.69% to 4.65% in Jun 2026 qtr

2 mutual fund schemes also hold this stock.

All shareholding details →

DateClientDealActionQuantityPriceExchange
27 Mar 2026 SHREE CAPITAL SERVICES LTD Bulk Sell 562,000 117.9500 NSE
27 Mar 2026 N B I INDUSTRIAL FINANCE COMPANY LIMITED Bulk Buy 561,900 117.9800 NSE
25 Mar 2026 DIGVIJAY FINLEASE LIMITED Bulk Sell 467,000 121.4200 NSE
12 Sep 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 685,574 197.8600 NSE
12 Sep 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 685,574 197.7100 NSE
12 Sep 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 685,574 197.7100 NSE
12 Sep 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 685,574 197.8600 NSE
19 Aug 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 481,731 187.9600 NSE
19 Aug 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 481,731 187.8900 NSE
29 Feb 2024 TWO ROADS TRADING PRIVATE LIMITED Bulk Buy 420,696 206.3500 NSE

All bulk and block deals →

Last 12 months ₹2.50 per share
Dividend yield 1.66%
Ex-dateSubjectPer share (₹)Record date
30 Jul 2026 Dividend - Rs1.50 Per Share 1.5000 30 Jul 2026
14 Nov 2025 Interim Dividend - Re 1 Per Share 1.0000 14 Nov 2025
29 Jul 2025 Dividend - Rs 1.50 Per Share 1.5000 29 Jul 2025
28 Nov 2024 Interim Dividend - Re 1 Per Share 1.0000 28 Nov 2024
18 Jul 2024 Annual General Meeting/Dividend - Rs 1.50 Per Share 1.5000 —
2 Apr 2024 Interim Dividend - Re 1 Per Share 1.0000 2 Apr 2024

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
3 Aug 2026 Financial Results Yes
18 May 2026 Financial Results/Dividend Yes
2 Feb 2026 Financial Results Yes
8 Nov 2025 Financial Results/Dividend Yes
6 Aug 2025 Financial Results Yes

Corporate Announcements

All 193 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST GPT Healthcare Ltd - 544131 - Closure of Trading Window
28 Sep 2026 Trading Window GPT Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
21 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates GPT Healthcare Limited has informed the Exchange about Schedule of meet
21 Sep 2026 Company Update GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
7 Aug 2026 Analysts/Institutional Investor Meet/Con. Call Updates GPT Healthcare Limited has informed the Exchange about Transcript
7 Aug 2026 Shareholders meeting GPT Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 06, 2026. Further, the company has informed the Exchange regarding voting results.
6 Aug 2026 Shareholders meeting GPT Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 06, 2026
4 Aug 2026 Analysts/Institutional Investor Meet/Con. Call Updates GPT Healthcare Limited has informed the Exchange about Link of Recording
4 Aug 2026 Copy of Newspaper Publication GPT Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
3 Aug 2026 Press Release Press Release on UFR for Q1FY2027

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.06)
  • Strong revenue growth YoY (17.8%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about GPT Healthcare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.